CXCR5 and neoplasm: In the study of Bai et al. [31], CD8+CXCR5+ T cells were identified as a potent subset of CD8+ T cells in PDAC, and over half of tumor-infiltrating CD8+ T cells were CD8+CXCR5+ T cells.